These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22128200)

  • 21. Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women.
    Shin D; Lee S; Lim KS; Park JS; Shin SG; Jang IJ; Yu KS
    Contraception; 2013 Jun; 87(6):750-5. PubMed ID: 23218856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol valerate/dienogest: in oral contraception.
    Hoy SM; Scott LJ
    Drugs; 2009 Aug; 69(12):1635-46. PubMed ID: 19678714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study.
    Gräser T; Müller A; Mellinger U; Mück AO; Lippert TH; Oettel M
    Maturitas; 2000 Jun; 35(3):253-61. PubMed ID: 10936742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory Women.
    Archer DF; Ng J; Chwalisz K; Chiu YL; Feinberg EC; Miller CE; Feldman RA; Klein CE
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31650182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dienogest.
    Foster RH; Wilde MI
    Drugs; 1998 Nov; 56(5):825-33; discussion 834-5. PubMed ID: 9829156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
    Hirata T; Izumi G; Takamura M; Saito A; Nakazawa A; Harada M; Hirota Y; Koga K; Fujii T; Osuga Y
    Gynecol Endocrinol; 2014 Oct; 30(10):726-9. PubMed ID: 24905725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women.
    Schütt B; Schultze-Mosgau MH; Draeger C; Chang X; Löwen S; Kaiser A; Rohde B
    J Clin Pharmacol; 2018 Feb; 58(2):228-239. PubMed ID: 28940451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.
    Okada H; Nakajima T; Yoshimura T; Yasuda K; Kanzaki H
    Mol Hum Reprod; 2001 Apr; 7(4):341-7. PubMed ID: 11279296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Mabrouk M; Paradisi R; Arena A; Del Forno S; Matteucci C; Zannoni L; Caprara G; Seracchioli R
    Gynecol Endocrinol; 2018 May; 34(5):399-403. PubMed ID: 29160135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis.
    Köhler G; Faustmann TA; Gerlinger C; Seitz C; Mueck AO
    Int J Gynaecol Obstet; 2010 Jan; 108(1):21-5. PubMed ID: 19819448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.
    Römer T
    Arch Gynecol Obstet; 2018 Oct; 298(4):747-753. PubMed ID: 30076546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Yanase T; Tsuneki I; Tamura M; Kurabayashi T
    Gynecol Endocrinol; 2014 Nov; 30(11):804-7. PubMed ID: 25060125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal and histological study on irregular genital bleeding in patients with endometriosis during treatment with dienogest, a novel progestational therapeutic agent.
    Irahara M; Harada T; Momoeda M; Tamaki Y
    Reprod Med Biol; 2007 Dec; 6(4):223-228. PubMed ID: 29699280
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention.
    Fathalla MF
    Int J Gynaecol Obstet; 2016 Mar; 132(3):356-8. PubMed ID: 26876699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of treatment with cyclic administration of dienogest after ovarian endometriotic cystectomy.
    Yanase T; Ishida M; Nishijima S; Morikawa K; Yokoo T; Takaki Y; Tsuneki I; Tamura M; Kurabayashi T
    Gynecol Endocrinol; 2015; 31(8):643-6. PubMed ID: 26291801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid metabolism during treatment of endometriosis with the progestin dienogest.
    Köhler G; Göretzlehner G; Brachmann K
    Acta Obstet Gynecol Scand; 1989; 68(7):633-5. PubMed ID: 2631529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review.
    Laganà AS; Vitale SG; Muscia V; Rossetti P; Buscema M; Triolo O; Rapisarda AM; Giunta L; Palmara V; Granese R; Frangež HB; Romano A
    Arch Gynecol Obstet; 2017 Mar; 295(3):661-667. PubMed ID: 27904953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of endometriosis with dienogest: preliminary report].
    Kamiński K; Fiegler P; Marr J; Moore C
    Ginekol Pol; 2001 May; 72(5):299-304. PubMed ID: 11526761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dienogest and the breast.
    Schindler AE; Henkel A; Christensen B; Oettel M; Moore C
    Gynecol Endocrinol; 2009 Jul; 25(7):472-4. PubMed ID: 19499407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term dienogest administration in patients with symptomatic adenomyosis.
    Neriishi K; Hirata T; Fukuda S; Izumi G; Nakazawa A; Yamamoto N; Harada M; Hirota Y; Koga K; Wada-Hiraike O; Fujii T; Osuga Y
    J Obstet Gynaecol Res; 2018 Aug; 44(8):1439-1444. PubMed ID: 29845696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.